{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-052539","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2024-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.837102+00:00","generated_at":"2026-05-28T22:50:43.794039+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Adam M. Koppel resigns from Foghorn Therapeutics board","bullets":["Adam M. Koppel, M.D., Ph.D., resigned from the Board effective December 29, 2024.","Resignation not due to any disagreement with the Company or Board.","Koppel served on the Audit Committee and Nominating and Corporate Governance Committee.","He was a Class II director with a term expiring at the 2025 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-052539","json":"https://secwatch.observer/filing/0001628280-24-052539.json","markdown":"https://secwatch.observer/filing/0001628280-24-052539.md","text":"https://secwatch.observer/filing/0001628280-24-052539.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/0001628280-24-052539-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828024052539/fhtx-20241229.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T22:50:43.794039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}